Blue Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Blue Capital's BMY Position: Q3 2026 in Review
Blue Capital sold out of Bristol-Myers Squibb (BMY) in Q3 2026, closing a stake of 18,381 shares — an estimated $1.06M sold.
Blue Capital first reported a position in BMY in Q4 2025 and held it in 3 quarters. The position peaked at $1.06M in Q2 2026. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Blue Capital reported no remaining Bristol-Myers Squibb position as of Q3 2026 after selling out during the quarter.
- Blue Capital sold 18,381 Bristol-Myers Squibb shares in Q3 2026, an estimated $1.06M.
- Blue Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and held it in 3 quarters.
- Blue Capital's Bristol-Myers Squibb position peaked at $1.06M in Q2 2026.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Blue Capital's 13F filing for Q3 2026, filed 13 Oct 2026.